Mr. James Thompson reports

CALLITAS HEALTH ACCELERATES COMMERCIAL LICENSING AND ENGAGES FEYEUR & TROGUE, A SPECIALTY HEALTHCARE CONSULTING FIRM

Freyeur & Trogue (F&T), of New York, N.Y., has been engaged by Callitas Health Inc. to provide management and business development consulting services to help optimize Callitas's product portfolio development and commercialization.

F&T is a specialty consulting and investment banking firm that provides a unique combination of advisory and consulting services to help life science and technology companies realize their growth potential. F&T helps clients identify and exploit new businesses, new markets, new products and new brands to create value for their company.

"We are excited about partnering with Freyeur & Trogue to advance our commercial development, licensing and strategic partnering strategies in the U.S. and multiple international markets, where discussions with potential partners have already begun," says James Thompson, interim president and chief executive officer. "Freyeur & Trogue bring decades of pharmaceutical development, partnering and fundraising expertise to help us accelerate our business."

Engaging F&T underscores Callitas's commitment to bring innovative and uniquely beneficial weight management and female health and wellness products to patients with unmet or underserved health care needs.

About Callitas Health Inc.

Formed in early 2015, Callitas Health is a clinical-stage company developing innovative technologies for obesity, weight management, and female health and wellness. In addition to its recent acquisitions of C-103, a reformulation of Orlistat, Extrinsa and assets from 40J's LLC, the company successfully launched ToConceive in North America as a clinically proven option for couples struggling with the inability to conceive.

We seek Safe Harbor.